{"name":"Zuyderland Medisch Centrum","slug":"zuyderland-medisch-centrum","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Dabigatran + clopidogrel","genericName":"Dabigatran + clopidogrel","slug":"dabigatran-clopidogrel","indication":"Acute coronary syndrome or post-percutaneous coronary intervention with atrial fibrillation","status":"marketed"},{"name":"Dabigatran + Ticagrelor","genericName":"Dabigatran + Ticagrelor","slug":"dabigatran-ticagrelor","indication":"Acute coronary syndrome with dual anticoagulant-antiplatelet therapy","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Artiss","genericName":"Artiss","slug":"artiss","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Dabigatran + clopidogrel","genericName":"Dabigatran + clopidogrel","slug":"dabigatran-clopidogrel","phase":"marketed","mechanism":"This combination uses dabigatran (a direct thrombin inhibitor) and clopidogrel (a P2Y12 platelet inhibitor) together to provide dual anticoagulant and antiplatelet effects.","indications":["Acute coronary syndrome or post-percutaneous coronary intervention with atrial fibrillation"],"catalyst":""},{"name":"Artiss","genericName":"Artiss","slug":"artiss","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dabigatran + Ticagrelor","genericName":"Dabigatran + Ticagrelor","slug":"dabigatran-ticagrelor","phase":"marketed","mechanism":"This combination uses dabigatran (a direct thrombin inhibitor) and ticagrelor (a P2Y12 platelet inhibitor) together to provide dual anticoagulant and antiplatelet effects for thrombotic prevention.","indications":["Acute coronary syndrome with dual anticoagulant-antiplatelet therapy"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1JQVlyZldXUHNjV3p1T3c2TUpETnR4cnBJbm5na1FucUhuWnZuOG05X1c3NjNFMXc0YXh5S05DTmpVS0VqWDhBRldHdW85RVlKZm1XeTRjUFdDVElndWRn?oc=5","date":"2024-11-01","type":"pipeline","source":"Nature","summary":"Boosting the accuracy of existing models by updating and extending: using a multicenter COVID-19 ICU cohort as a proxy - Nature","headline":"Boosting the accuracy of existing models by updating and extending: using a multicenter COVID-19 ICU cohort as a proxy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNTTVlcE9TNHdFMmFZMktfejRJT0UwWVU0aUg4NU9wdWY5OF9JYW9CU3BVV2JHMUVMbWFyRERIUVpIQTVpZlZEUElqaFFOQXdQQlZYWUNCd2hkRHZXdl9xM0VjczY5VUM3UjJMV05tcHdoeXJob1NHX3RoakpzVUdmb0c1Z0R1TG5pQW1lTlg2ckZkNldnakZlaFpfXzdrX1hpTkxpUGszbnE3anNqTFNjUENBY0NGTzZmWjF2UVZqM0h4YkM4aWxKQkM1TQ?oc=5","date":"2022-07-05","type":"pipeline","source":"Dove Medical Press","summary":"ORR - Dove Medical Press","headline":"ORR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE8yRS1OemlsaUdFeVRKS0xMV1V5b3R5bUt1bDJrMHd4YlZjNGFNaU5lSUFXZzVYU054V1JhRmhGWEdhWXd3VmZBMm1uX0NnQzNYYVdLZFpnY3FSb2s5eW8w?oc=5","date":"2022-01-14","type":"regulatory","source":"Nature","summary":"Better COVID-19 Intensive Care Unit survival in females, independent of age, disease severity, comorbidities, and treatment | Scientific Reports - Nature","headline":"Better COVID-19 Intensive Care Unit survival in females, independent of age, disease severity, comorbidities, and treatm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE1idVBvclJXTnljSUhFQUNVc0pOTGJyanQwT0FIcVJYc1RYa3c1dXRYTDVWVHhlTHp3Y0tKQ2UwWmY0RGVEWlRULXJSanQzVjlqamdIMHhn?oc=5","date":"2020-05-27","type":"pipeline","source":"Medscape","summary":"No Laughing Matter: Illicit Use of Nitrous Oxide on the Rise? - Medscape","headline":"No Laughing Matter: Illicit Use of Nitrous Oxide on the Rise?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1adC1SUGZ2ZUI2NGpKMTJOZFp4RkhyQ2tKS1h0Q0gxd01mMk9uSHRiRWFGV0ZEZkcwT25Mb3pISjdYeklXa1o3SERld28zSFJqSElSTlB5d3B0Wm5EZHhMME11bFhoYjNXM05KY0pwU1k5Z1pDRnpneVhTN2VfR28?oc=5","date":"2019-03-21","type":"trial","source":"University of St Andrews","summary":"Securing the future of medical data - University of St Andrews","headline":"Securing the future of medical data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5RMFFoZkVfbThDblc1TnRDdVlKRnBzVzEwTGdvb1FpYUtUUTd2MDF6SUg2c1RkWWhua3c5UkhlLUlQNFFMV0hlemdNRk5oSFh1anVr?oc=5","date":"2017-01-19","type":"pipeline","source":"Nature","summary":"The effects of missed doses of amlodipine and losartan on blood pressure in older hypertensive patients - Nature","headline":"The effects of missed doses of amlodipine and losartan on blood pressure in older hypertensive patients","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}